Friday, July 25, 2014 6:07:28 PM
"We continue to be pleased with the contribution of our Mekonza subsidiary and its steadily increasing revenue flow that has been able to grow and withstand outside industry obstacles," commented CEO Thu Le. "The stability of Mekonza operation has permitted us to aggressively implement our complementary MMJ initiatives that are already beginning to grow revenue from a number of revenue streams. We look forward to a positive 2014 and will continue to report all developments."
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM